SEC 13F Intelligence

Pggm Investments / BMRN

Pggm Investments’s Biomarin Pharmaceutical Inc Position

Does Pggm Investments own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 518.0K shares worth $28M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$28M
Q3 2025
Shares
518.0K
% of Portfolio
+0.45%
Quarters Held
5
position exited

Position History BMRN

Reported value by quarter
Q3 ’24: $15MQ3 ’24Q4 ’24: $16MQ4 ’24Q1 ’25: $25MQ1 ’25Q2 ’25: $28MQ2 ’25Q3 ’25: $28MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025518.0K$28M+0.45%
Q2 2025518.0K$28M+0.49%
Q1 2025349.6K$25M+0.33%
Q4 2024243.7K$16M+0.21%
Q3 2024217.6K$15M+0.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pggm Investments’s full portfolio or all institutional holders of BMRN.